 |
|
|
| |
Renal and Bone Safety of Tenofovir Alafenamide
vs Tenofovir Disoproxil Fumarate
|
| |
| |
Combined Safety Results of Studies GS-US-292-0104 and GS-US-292-0111
Reported by Jules Levin
CROI 2015 Feb 23-26, Seattle, WA
Webcast
http://www.croiwebcasts.org/console/player/25797?mediaType=slideVideo&
Paul Sax1, Michael Saag2, Michael Yin3, Frank Post4, Shinichi Oka5, Ellen Koenig6, Benoit Trottier7, Jaime Andrade-Villanueva8,
Huyen Cao9, Marshall Fordyce9
1Brigham and Women's Hospital and Harvard Medical School, Boston, MA; 2University of Alabama Birmingham, Birmingham, AL; 3College of Physicians and Surgeons, Columbia University, New York, NY; 4King's College, London, UK; 5National Center for Global Health and Medicine, Tokyo, Japan; 6Dominican Institute for Virologic Studies, Santo Domingo, Dominican Republic; 7Clinique Medicale L'Actuale in Montreal, Montreal, Canada; 8Unidad de VIH del Hospital Civil de Guadalajara, Guadalajara, Mexico; 9Gilead Sciences, Foster City, CA
|
| |
|
|
|
|
|
